Sortilin and hypertension.

Roberta Avvisato, Stanislovas S Jankauskas, Fahimeh Varzideh, Urna Kansakar, Pasquale Mone, Gaetano Santulli

Current opinion in nephrology and hypertension 2023 Mar 01

filter terms:

The current review aims to present the latest scientific updates on the role of Sortilin in the pathophysiology of hypertension. The main focus of this systematic overview is on the functional contribution of Sortilin to the pathogenesis of hypertension. Sortilin is a glycoprotein mostly known for its actions as a trafficking molecule directing proteins to specific secretory or endocytic compartments of the cell. Emerging evidence indicates that Sortilin is associated with pathological conditions, including inflammation, arteriosclerosis, dyslipidemia, insulin resistance, and vascular calcification. Most recently, Sortilin has been shown to finely control endothelial function and to drive hypertension by modulating sphingolipid/ceramide homeostasis and by triggering oxidative stress. The latest findings linking Sortilin and hypertension that are herein discussed can inspire novel areas of research which could eventually lead to the discovery of new therapeutic strategies in cardiovascular medicine. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Citation

Roberta Avvisato, Stanislovas S Jankauskas, Fahimeh Varzideh, Urna Kansakar, Pasquale Mone, Gaetano Santulli. Sortilin and hypertension. Current opinion in nephrology and hypertension. 2023 Mar 01;32(2):134-140